CareDx Inc., a leading precision medicine company focused on transplant care, has announced a strategic collaboration with 10x Genomics, a leader in single cell and spatial biology. Together, they will launch ImmuneScape™, a multiomics research initiative aimed at decoding the complex immune mechanisms underlying organ transplant rejection and therapeutic response. The program will leverage 10x Genomics’ Xenium spatial and Chromium Flex single cell platforms to generate high-resolution maps of immune activity in transplant patients. Insights from ImmuneScape are intended to drive innovation in personalized transplant medicine and support future clinical diagnostic development.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CareDx Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260107073051) on January 07, 2026, and is solely responsible for the information contained therein.